Here we demonstrate the decreased vascularization of these xenografts with stable CDK5 shRNA HUH7 cells (Figure 3), and thus show that the anti-angiogenic effects of CDK5 reduction are not restricted to the endothelial cells, but do also originate in the HCC cells themselves. Here, CDK5 is linked to hepatocellular carcinoma.